Lilly, Pfizer Land on China’s First Private Insurance List
PositiveFinancial Markets

- Eli Lilly & Co., Pfizer Inc., and Johnson & Johnson have been included in China's first innovative drug catalog, which marks a significant step in the country's healthcare landscape by allowing private insurance coverage for these advanced treatments.
- This development is expected to enhance market access for these pharmaceutical companies, potentially increasing their sales and solidifying their presence in the rapidly evolving Chinese healthcare market.
— via World Pulse Now AI Editorial System






